BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23891150)

  • 1. Structure-based design of covalent Siah inhibitors.
    Stebbins JL; Santelli E; Feng Y; De SK; Purves A; Motamedchaboki K; Wu B; Ronai ZA; Liddington RC; Pellecchia M
    Chem Biol; 2013 Aug; 20(8):973-82. PubMed ID: 23891150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.
    Zhang Q; Wang Z; Hou F; Harding R; Huang X; Dong A; Walker JR; Tong Y
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3095-3105. PubMed ID: 27776223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the substrate binding site of Siah ubiquitin ligase.
    House CM; Hancock NC; Möller A; Cromer BA; Fedorov V; Bowtell DD; Parker MW; Polekhina G
    Structure; 2006 Apr; 14(4):695-701. PubMed ID: 16615911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling.
    Polekhina G; House CM; Traficante N; Mackay JP; Relaix F; Sassoon DA; Parker MW; Bowtell DD
    Nat Struct Biol; 2002 Jan; 9(1):68-75. PubMed ID: 11742346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma].
    Brauckhoff A; Ehemann V; Schirmacher P; Breuhahn K
    Verh Dtsch Ges Pathol; 2007; 91():269-77. PubMed ID: 18314624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic analysis of the SINA/SIAH ubiquitin E3 ligase family in Metazoa.
    Pepper IJ; Van Sciver RE; Tang AH
    BMC Evol Biol; 2017 Aug; 17(1):182. PubMed ID: 28784114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
    Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
    Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SIAH E3 ubiquitin ligases promote Wnt/β-catenin signaling through mediating Wnt-induced Axin degradation.
    Ji L; Jiang B; Jiang X; Charlat O; Chen A; Mickanin C; Bauer A; Xu W; Yan X; Cong F
    Genes Dev; 2017 May; 31(9):904-915. PubMed ID: 28546513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
    Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
    J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siah proteins: novel drug targets in the Ras and hypoxia pathways.
    House CM; Möller A; Bowtell DD
    Cancer Res; 2009 Dec; 69(23):8835-8. PubMed ID: 19920190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.
    Johansson H; Isabella Tsai YC; Fantom K; Chung CW; Kümper S; Martino L; Thomas DA; Eberl HC; Muelbaier M; House D; Rittinger K
    J Am Chem Soc; 2019 Feb; 141(6):2703-2712. PubMed ID: 30657686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siah: a promising anticancer target.
    Wong CS; Möller A
    Cancer Res; 2013 Apr; 73(8):2400-6. PubMed ID: 23455005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converting One-Face α-Helix Mimetics into Amphiphilic α-Helix Mimetics as Potent Inhibitors of Protein-Protein Interactions.
    Lee JH; Oh M; Kim HS; Lee H; Im W; Lim HS
    ACS Comb Sci; 2016 Jan; 18(1):36-42. PubMed ID: 26651509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling.
    Bjij I; Ramharack P; Khan S; Cherqaoui D; Soliman MES
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31466292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I Siah substrate!
    Briant DJ; Ceccarelli DF; Sicheri F
    Structure; 2006 Apr; 14(4):627-8. PubMed ID: 16615900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the Effects of SIAH Ubiquitin E3 Ligases on Lysine Acetyl Transferases.
    Hagenbucher J; Stekman H; Rodriguez-Gil A; Kracht M; Schmitz ML
    Methods Mol Biol; 2017; 1510():297-312. PubMed ID: 27761830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.
    Avraham E; Szargel R; Eyal A; Rott R; Engelender S
    J Biol Chem; 2005 Dec; 280(52):42877-86. PubMed ID: 16174773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity-enabled bioreactivity to generate covalent peptide inhibitors of p53-Mdm4.
    Hoppmann C; Wang L
    Chem Commun (Camb); 2016 Apr; 52(29):5140-3. PubMed ID: 26996321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
    Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
    Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.